Antimicrobial resistance poses one of the gravest threats to global public health today. The rise of multidrug-resistant organisms has rendered many "last line" antibiotic treatments ineffective. To tackle this challenge, it is essential that healthcare providers accurately determine which antimicrobial agents will effectively treat a given infection. This is where antimicrobial susceptibility testing plays a crucial role.
What is Antimicrobial Susceptibility Testing?
Antimicrobial susceptibility testing, commonly called an AST or culture sensitivity, is a laboratory procedure that determines the sensitivity of pathogenic bacteria, viruses, fungi or parasites to different antimicrobial medications such as antibiotics, antivirals, antifungals and antiparasitic drugs. In a susceptibility test, the microorganism that causes an infection is exposed to various antimicrobials to see which drugs can inhibit or kill its growth.
The goal of AST is to identify the most effective antimicrobial therapy for a particular patient. By knowing which antimicrobial agents a microbe is sensitive or resistant to, doctors can customize treatment regimens with drugs that have the highest likelihood of success for that individual case. This maximizes cure rates while reducing the development of further resistance.
Importance of AST in the Era of Antimicrobial Resistance
The increasing problem of aAntimicrobial Susceptibility Testing resistance has made AST a critical component of infection management. When microbes develop resistance to frontline antimicrobials, it leaves physicians with fewer treatment options for common infections. Even minor infections can become untreatable and life-threatening without effective antibiotics.
AST helps counter resistance by:
- Detecting emerging resistance early, allowing doctors to change prescriptions before treatment fails
- Avoiding the overuse of broad-spectrum antibiotics when narrow-spectrum drugs remain effective
- Promoting the use of antimicrobials to which pathogens have not yet developed resistance
- Monitoring resistance trends locally and globally to inform treatment guidelines
Without AST data, doctors would need to treat empirically and risk prescribing unnecessary broad-spectrum drugs or medications the pathogen is resistant to. Both scenarios accelerate the development of resistance. By getting individualized AST results, physicians gain valuable intelligence to optimize treatment selection.
Methods of Antimicrobial Susceptibility Testing
There are several standardized methods used in clinical microbiology labs to conduct AST:
Disk Diffusion Test: One of the most common techniques, it involves applying filter paper discs impregnated with antimicrobials onto culture plates inoculated with the test organism. Inhibition zone sizes around each disk indicate sensitivity.
Automated Systems: Fully automated systems like the VITEK and Phoenix can rapidly test antimicrobial susceptibility directly from positive blood cultures or other specimens. They produce digital results within 24 hours.
Broth Microdilution Method: Used as a reference standard by the Clinical and Laboratory Standards Institute, it tests minimum inhibitory concentrations (MICs) of drugs through serial broth dilutions inoculated with the organism.
Agar Dilution Method: Similar to broth microdilution but uses antimicrobial-impregnated agar plates instead of broth. It provides qualitative sensitive/resistant categories.
Molecular Technologies: Newer PCR- and DNA sequencing-based techniques can genotype resistant genes directly from clinical specimens for fastAST.
While methods differ in complexity, the goal is the same - assess how well common antimicrobials work against a patient's infection-causing pathogen.
Importance of AST in Special Circumstances
There are some clinical scenarios where AST plays an especially pivotal role:
- Healthcare-associated Infections: Due to past exposure to antibiotics and healthcare settings, these infections are more likely to involve multidrug-resistant organisms requiring AST guidance.
- Bacteremia and Fungal Infections: Bloodstream infections and invasive fungal diseases demand prompt, effective treatment. With AST, the right antifungals or antibiotics can be selected quickly.
- Recurrent or Difficult-to-treat Infections: Patients who fail multiple courses of therapy present diagnostic and management challenges that AST can help overcome.
- Outbreak Situations: AST aids outbreak control by rapidly detecting resistant strains and guiding empiric treatments during prelim investigations.
In summary, antimicrobial susceptibility testing is a fundamental tool for clinicians and laboratories to fight the growing public health crisis of antimicrobial resistance. By providing individualized data on successful drug options, AST optimizes treatment selection and case management while also helping curb further resistance development. Its role in infection control will remain indispensable for years to come.
Get more insights on- Antimicrobial Susceptibility Testing
